Raymond James Trust N.A. increased its position in shares of CME Group Inc (NASDAQ:CME) by 10.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,935 shares of the financial services provider’s stock after purchasing an additional 1,920 shares during the period. Raymond James Trust N.A.’s holdings in CME Group were worth $3,445,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in the stock. Acadian Asset Management LLC increased its stake in CME Group by 591.0% during the 4th quarter. Acadian Asset Management LLC now owns 3,676 shares of the financial services provider’s stock worth $691,000 after acquiring an additional 3,144 shares during the period. Norges Bank bought a new position in shares of CME Group in the 4th quarter valued at $597,417,000. Thrivent Financial for Lutherans increased its stake in shares of CME Group by 8.2% in the 4th quarter. Thrivent Financial for Lutherans now owns 15,815 shares of the financial services provider’s stock valued at $2,975,000 after purchasing an additional 1,194 shares during the last quarter. First United Bank Trust increased its stake in shares of CME Group by 2.5% in the 1st quarter. First United Bank Trust now owns 7,725 shares of the financial services provider’s stock valued at $1,271,000 after purchasing an additional 185 shares during the last quarter. Finally, Public Employees Retirement System of Ohio increased its stake in shares of CME Group by 49.7% in the 4th quarter. Public Employees Retirement System of Ohio now owns 335,039 shares of the financial services provider’s stock valued at $63,028,000 after purchasing an additional 111,297 shares during the last quarter. 84.85% of the stock is owned by institutional investors and hedge funds.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total value of $420,675.00. Following the transaction, the chief financial officer now directly owns 35,354 shares of the company’s stock, valued at approximately $5,949,017.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronald A. Pankau sold 200 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $182.90, for a total value of $36,580.00. Following the completion of the transaction, the director now directly owns 3,600 shares in the company, valued at $658,440. The disclosure for this sale can be found here. Insiders sold a total of 28,489 shares of company stock worth $4,948,996 over the last three months. 1.20% of the stock is owned by company insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.02. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The firm’s revenue was up 37.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.12 EPS. Analysts anticipate that CME Group Inc will post 6.82 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 25th. Stockholders of record on Friday, March 8th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.73%. This is an increase from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend was Thursday, March 7th. CME Group’s payout ratio is currently 43.99%.
Several equities analysts have recently issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $204.00 price target on shares of CME Group in a research note on Wednesday, January 9th. BidaskClub lowered CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, January 9th. Bank of America restated a “neutral” rating and set a $191.00 price objective (down previously from $200.00) on shares of CME Group in a research report on Friday, January 11th. They noted that the move was a valuation call. JPMorgan Chase & Co. initiated coverage on CME Group in a research report on Friday, February 15th. They set an “underweight” rating and a $164.00 price objective on the stock. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $210.00 price objective on shares of CME Group in a research report on Friday, February 15th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $192.00.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://weekherald.com/2019/04/15/raymond-james-trust-n-a-grows-position-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: What Are Cryptocurrencies?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.